Quality of life in the GLARIUS trial randomizing bevacizumab/irinotecan versus temozolomide in newly diagnosed, MGMT-nonmethylated glioblastoma

  • Schäfer, Niklas
  • Proescholdt, Martin
  • Steinbach, Joachim P
  • Weyerbrock, Astrid
  • Hau, Peter
  • Grauer, Oliver
  • Goldbrunner, Roland
  • Friedrich, Franziska
  • Rohde, Veit
  • Ringel, Florian
  • Schlegel, Uwe
  • Sabel, Michael
  • Ronellenfitsch, Michael W
  • Uhl, Martin
  • Grau, Stefan
  • Hänel, Mathias
  • Schnell, Oliver
  • Krex, Dietmar
  • Vajkoczy, Peter
  • Tabatabai, Ghazaleh
  • Mack, Frederic
  • Schaub, Christina
  • Tzaridis, Theophilos
  • Nießen, Michael
  • Kebir, Sied
  • Leutgeb, Barbara
  • Urbach, Horst
  • Belka, Claus
  • Stummer, Walter
  • Glas, Martin
  • Herrlinger, Ulrich
Neuro-Oncology 20(7):p 975-985, July 2018. | DOI: 10.1093/neuonc/nox204
Copyright © Copyright Oxford University Press 2018.
View full text|Download PDF